An increase in high-fat, high-fructose foods in people's diets has contributed to a dramatic increase in type 2 diabetes.

We are excited to collaborate with Biogen on litifilimab,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “Royalty Pharma offers tailored, win-win funding solutions for ...

Royalty Pharma plc (Nasdaq: RPRX) today announced that it has entered into an agreement with Biogen to provide research and development (R&D) funding of up ...

Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the momentum, experts worry.

Lattice Semiconductor (NASDAQ:LSCC – Get Free Report) had its price target boosted by Stifel Nicolaus from $65.00 to $70.00 in a report released on Tuesday,Benzinga reports. The firm presently has a ...

The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...

Co (market cap: $42.4 billion) reported robust Q4 2024 earnings, exceeding Wall Street forecasts with adjusted earnings per share (EPS) of $0.99, compared to the expected $0.82. Revenue also surpassed ...